MEDIA

Latest News

Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, as well as financial technology services for aesthetic practices.

16 December 2020

Governor Lee, Commissioner Rolfe Announce Revance Therapeutics to Relocate Global Headquarters to Nashville

16 December 2020

Nashville Business Journal: Revance Therapeutics moves HQ from California to Nashville; CEO counting on ability to recruit to fill 150 jobs

10 December 2020

2020 Future of Beauty Awards

20 October 2020

DaxibotulinumtoxinA Meets Primary End Point in Cervical Dystonia Study

14 October 2020

Revance Builds Therapeutics Credibility For DaxibotulinumtoxinA Ahead Of Aesthetics Launch

09 September 2020

DaxibotulinumtoxinA for injection shows consistent efficacy in open-label study

19 August 2020

Novel botulinum toxin type A earns high marks for forehead lines

04 August 2020

Revance Reports Positive Results in Two Phase 2a Studies of DAXI

29 July 2020

Dustin S. Sjuts of Revance Therapeutics: Five Things You Need To Know To Succeed In The Modern Beauty Industry

27 July 2020

DaxibotulinumtoxinA Aims to Be Next Big Post-Stroke Spasticity Treatment

23 July 2020

Bloomberg: Revance Completes Previously Announced Acquisition of HintMD and its Proprietary Fintech Platform for Aesthetic Practices

07 July 2020

Modern Aesthetics: Revance’s DaxibotulinumtoxinA for Injection Looks Good in Phase 2 Studies of Forehead Lines and Crow’s Feet